merged_ftc-pharmacy-benefit-managers-drug-prices.txt
<other>I will carefully review the article to answer each question directly based solely on the text.</other>

<question_number>1</question_number>
<answer>The FTC has not yet brought a lawsuit; the report criticizes pharmacy benefit managers for potentially inflating drug costs and squeezing independent pharmacies</answer>

<question_number>2</question_number>
<answer>N/A</answer>

<question_number>3</question_number>
<answer>$1.6 billion in revenue over less than three years for the biggest three conglomerates from practices involving generic cancer drugs</answer>